Sectors
AIFF
Firefly Neuroscience, Inc.
1.08
2 x 0.83
2 x 1.39
bid
ask
+
0.00
0.00%
02:02 PM
timesize
| Ytd | 22.73% | |
| 1y | -59.25% |
1.05
day range
1.17
0.62
52 week range
3.15
| Open | 1.05 | Prev Close | 1.08 | Low | 1.05 | High | 1.17 | Mkt Cap | 16.95M |
| Vol | 78.61K | Avg Vol | 189.94K | EPS | -0.51 | P/E | N/A | Forward P/E | N/A |
| Beta | 0.57 | Short Ratio | 0.87 | Inst. Own | 1.76% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 1.16 | 200-d Avg | 1.42 | 1yr Est | 0.00 |
| Income Statement | |||
| Total Revenue | 514.00K | ||
| Revenues (USD) | 514.00K | ||
| Cost of Revenue | 261.00K | ||
| Gross Profit | 253.00K | ||
| Operating Expenses | 2.23M | ||
| Research and Development Expense | 525.00K | ||
| Selling, General and Administrative Expense | 1.70M | ||
| Operating Income | -1.97M | ||
| Interest Expense | 6.00K | ||
| Net Income | -1.98M | ||
| Net Income Common Stock | -1.98M | ||
| Net Income Common Stock (USD) | -1.98M | ||
| Consolidated Income | -1.98M | ||
| Earnings per Basic Share | -0.10 | ||
| Earnings per Basic Share (USD) | -0.10 | ||
| Earnings per Diluted Share | -0.10 | ||
| Earning Before Interest & Taxes (EBIT) | -1.98M | ||
| Earning Before Interest & Taxes (USD) | -1.98M | ||
| Weighted Average Shares | 20.58M | ||
| Weighted Average Shares Diluted | 20.58M | ||
| Balance Sheet | |||
| Cash and Equivalents | 9.23M | ||
| Cash and Equivalents (USD) | 9.23M | ||
| Trade and Non-Trade Receivables | 188.00K | ||
| Current Assets | 10.23M | ||
| Property, Plant & Equipment Net | 230.00K | ||
| Total Assets | 16.77M | ||
| Current Liabilities | 2.10M | ||
| Total Liabilities | 2.11M | ||
| Accumulated Retained Earnings (Deficit) | -115.56M | ||
| Shareholders Equity | 14.66M | ||
| Shareholders Equity (USD) | 14.66M | ||
| Assets Non-Current | 6.54M | ||
| Deferred Revenue | 222.00K | ||
| Goodwill and Intangible Assets | 5.96M | ||
| Inventory | 44.00K | ||
| Liabilities Non-Current | 7.00K | ||
| Trade and Non-Trade Payables | 1.36M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 47.00K | ||
| Net Cash Flow from Financing | 7.89M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 6.10M | ||
| Capital Expenditure | -42.00K | ||
| Issuance (Purchase) of Equity Shares | 7.89M | ||
| Net Cash Flow from Investing | -42.00K | ||
| Net Cash Flow from Operations | -1.75M | ||
| Share Based Compensation | 268.00K | ||